Ono Pharmaceutical Co., Ltd. OPHLF
14.90 USD 0.00 (+0.00%)
At closeNov 11, 2026, 4:00 PM EST
14.90 Day range 14.90
11.08 52-week range 18.67
- YTD
- +15.77%
- 1 year
- +22.13%
News
defenseworld.net Critical Comparison: Ovid Therapeutics (NASDAQ:OVID) & Ono Pharmaceutical (OTCMKTS:OPHLF) Ono Pharmaceutical (OTCMKTS:OPHLF - Get Free Report) and Ovid Therapeutics (NASDAQ: OVID - Get Free Report) are both healthcare companies, but which is the superior investment? We will contrast the…
businesswire.com Ono Pharma Announces Results From Five Phase 2 Clinical Studies of ONO-1110, an Endocannabinoid Modulator OSAKA, Japan--(BUSINESS WIRE)--Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”) today announced that ONO-1110, an endocannabinoid modulator,…
defenseworld.net Ono Pharmaceutical (OTCMKTS:OPHLF) Shares Gap Down – Time to Sell? Ono Pharmaceutical Co. (OTCMKTS:OPHLF - Get Free Report) gapped down before the market opened on Monday. The stock had previously closed at $16.11, but opened at $13.6650. Ono Pharmaceutical shares…
zacks.com Ono Pharmaceutical Co. (OPHLF) Soars 13.9%: Is Further Upside Left in the Stock? Ono Pharmaceutical Co. (OPHLF) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further…
defenseworld.net Reviewing Iterum Therapeutics (NASDAQ:ITRM) and Ono Pharmaceutical (OTCMKTS:OPHLF) Iterum Therapeutics (NASDAQ: ITRM - Get Free Report) and Ono Pharmaceutical (OTCMKTS:OPHLF - Get Free Report) are both healthcare companies, but which is the superior investment? We will compare the…
businesswire.com Ono Pharma Enters into a Drug Discovery Partnership with Aitia in Neurological Diseases OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”) today announced that it has entered into a drug…
zacks.com Are Investors Undervaluing Ono Pharmaceutical Co. (OPHLF) Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the…
zacks.com Ono Pharmaceutical Co. (OPHLF) Q1 Earnings and Revenues Top Estimates Ono Pharmaceutical Co. (OPHLF) came out with quarterly earnings of $0.4 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.26 per share a year ago.
zacks.com Earnings Preview: Ono Pharmaceutical Co. (OPHLF) Q1 Earnings Expected to Decline Ono Pharmaceutical Co. (OPHLF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
zacks.com Strength Seen in Ono Pharmaceutical Co. (OPHLF): Can Its 9.2% Jump Turn into More Strength? Ono Pharmaceutical Co. (OPHLF) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be…
zacks.com Should Value Investors Buy Ono Pharmaceutical Co. (OPHLF) Stock? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the…
zacks.com Ono Pharmaceutical Co. (OPHLF) Moves 10.4% Higher: Will This Strength Last? Ono Pharmaceutical Co. (OPHLF) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further…
businesswire.com Ono Pharma Announces Oral Presentation of New Data from the Phase 2 Clinical Study of ONO-4578 (EP4 antagonist) in Certain Gastric Cancers at the ASCO 2026 Annual Meeting OSAKA, Japan--(BUSINESS WIRE)--Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”) today announced the results of the phase 2 clinical study…
businesswire.com Ono Pharma Announces New Drug Discovery Collaboration with Congruence Therapeutics in the Priority Areas of Neurology and Immunology OSAKA, Japan & MONTREAL--(BUSINESS WIRE)--Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) announced that it has entered into an agreement to expand the drug…
businesswire.com Deciphera Pharmaceuticals Announces U.S. Food and Drug Administration Acceptance for Filing of New Drug Application for Tirabrutinib in Patients with Relapsed or Refractory PCNSL OSAKA, Japan & WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today…
seekingalpha.com Ono Pharmaceutical Co., Ltd. (OPHLY) Presents at 44th Annual J.P. Ono Pharmaceutical Co., Ltd. (OPHLY) Presents at 44th Annual J.P.
seekingalpha.com Ono Pharmaceutical Co., Ltd. (OPHLF) Q1 FY2025 Earnings Call Transcript Ono Pharmaceutical Co., Ltd. (OTCPK:OPHLF) Q1 FY2025 Earnings Conference Call August 1, 2025 1:00 AM ET Company Participants Hirokazu Kitada - Corporate Participant Sales and Marketing - Corporate…
seekingalpha.com Ono Pharmaceutical Co., Ltd. (OPHLF) Q1 2024 Earnings Call Transcript Ono Pharmaceutical Co., Ltd. (OTCPK:OPHLF) Q1 2024 Earnings Conference Call May 9, 2024 8:30 PM ET Company Participants Gyo Sagara - Representative, Director, Chairman of the Board and CEO Tatsuya…
reuters.com Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion Japan's Ono Pharmaceutical Co said on Tuesday its $2.4 billion takeover of Deciphera Pharmaceuticals is a "first step" in expanding in U.S. and European markets.
invezz.com ONO to buy Deciphera Pharmaceuticals at a huge premium Deciphera Pharmaceuticals Inc (NASDAQ: DCPH) is up a whopping 75% today after ONO Pharmaceutical (TYO: 4528) announced plans of buying it for $2.4 billion. Deciphera Pharmaceuticals stock valued at…